P-45 An open-label, phase 2 study of patritumab deruxtecan in patients with previously treated advanced/metastatic colorectal cancer
Titel:
P-45 An open-label, phase 2 study of patritumab deruxtecan in patients with previously treated advanced/metastatic colorectal cancer
Auteur:
Raghav, K. Yoshino, T. Taniguchi, H. Tejpar, S. Vogel, A. Wainberg, Z. Yamaguchi, K. Fakih, M. Pedersen, K. Bando, K. Kawakami, H. Beck, J. Kanai, M. Liu, Y. Mekan, S. Pudussery, G. Qiu, Y. Kopetz, S.